risks of glp 1 agonists The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions GLP-1RA Essentials in Gastroenterology: Side
Description
doi: 10.1016/j.jhep.2015.11.014
All DPP-4 inhibitors can be given in a standard dose without the need for dose titrations (10)
PMID: 19703814
The injectable form is more prevalent and includes drugs such as liraglutide, exenatide, and semaglutide
